FXR agonist activity of conformationally constrained analogs of GW 4064
Adwoa Akwabi-Ameyaw, Jonathan Y. Bass, Richard D. Caldwell et al. · Bioorganic & Medicinal Chemistry Letters · 2009
Cited by 63 works. doi:10.1016/j.bmcl.2009.06.062
Authors
- Adwoa Akwabi-Ameyaw
- Jonathan Y. Bass
- Richard D. Caldwell
- Justin A. Caravella
- Lihong Chen
- Katrina L. Creech
- David N. Deaton
- Kevin P. Madauss
- Harry B. Marr
- Robert B. McFadyen
- Aaron B. Miller
- Frank Navas
- Derek J. Parks
- Paul K. Spearing
- Dan Todd
- Shawn P. Williams
- G. Bruce Wisely
References
- Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
- Identification of a nuclear receptor that is activated by farnesol metabolites
- Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
- Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
- Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
- Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
- Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
- Farnesoid X receptor is essential for normal glucose homeostasis
- The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
- The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis